{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:18:39Z","timestamp":1783775919397,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11102-018-0909-z","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T06:24:28Z","timestamp":1536128668000},"page":"571-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3752-8629","authenticated-orcid":false,"given":"Emanuele","family":"La Corte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iyan","family":"Younus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2277-6833","authenticated-orcid":false,"given":"Francesca","family":"Pivari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Selimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Ottenhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Pisapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana A.","family":"Dobri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore H.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"key":"909_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2868","author":"PK Brastianos","year":"2014","unstructured":"Brastianos PK, Taylor-Weiner A, Manley PE et al (2014) Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. \n                    https:\/\/doi.org\/10.1038\/ng.2868","journal-title":"Nat Genet"},{"key":"909_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00401-005-1004-x","volume":"109","author":"R Buslei","year":"2005","unstructured":"Buslei R, Nolde M, Hofmann B et al (2005) Common mutations of b-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 109:589\u2013597. \n                    https:\/\/doi.org\/10.1007\/s00401-005-1004-x","journal-title":"Acta Neuropathol"},{"key":"909_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40478-016-0287-6","volume":"4","author":"A H\u00f6lsken","year":"2016","unstructured":"H\u00f6lsken A, Sill M, Merkle J et al (2016) Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles. Acta Neuropathol Commun 4:20. \n                    https:\/\/doi.org\/10.1186\/s40478-016-0287-6","journal-title":"Acta Neuropathol Commun"},{"key":"909_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11060-017-2465-1","volume":"133","author":"PB Malgulwar","year":"2017","unstructured":"Malgulwar PB, Nambirajan A, Pathak P et al (2017) Study of \u03b2-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases. J Neurooncol 133:487\u2013495. \n                    https:\/\/doi.org\/10.1007\/s11060-017-2465-1","journal-title":"J Neurooncol"},{"key":"909_CR5","volume-title":"WHO classification of tumors of the central nervous system (Revised 4th edition)","author":"DN Louis","year":"2016","unstructured":"Louis DN, Ohgaki H, Wiestler ODCW (2016) WHO classification of tumors of the central nervous system (Revised 4th edition). IARC, Lyon"},{"key":"909_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/er.2013-1115","volume":"35","author":"HL M\u00fcller","year":"2014","unstructured":"M\u00fcller HL (2014) Craniopharyngioma. Endocr Rev 35:513\u2013543. \n                    https:\/\/doi.org\/10.1210\/er.2013-1115","journal-title":"Endocr Rev"},{"key":"909_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3171\/jns.1990.73.1.0012","volume":"73","author":"TE Adamson","year":"1990","unstructured":"Adamson TE, Wiestler OD, Kleihues P, Ya\u015fargil MG (1990) Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 73:12\u201317. \n                    https:\/\/doi.org\/10.3171\/jns.1990.73.1.0012","journal-title":"J Neurosurg"},{"key":"909_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3171\/jns.1995.83.2.0206","volume":"83","author":"TB Crotty","year":"1995","unstructured":"Crotty TB, Scheithauer BW, Young WF et al (1995) Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 83:206\u2013214. \n                    https:\/\/doi.org\/10.3171\/jns.1995.83.2.0206","journal-title":"J Neurosurg"},{"key":"909_CR9","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1530\/EJE-15-0957","volume":"174","author":"PK Brastianos","year":"2016","unstructured":"Brastianos PK, Santagata S (2016) BRAF V600E mutations in papillary craniopharyngioma. Eur J Endocrinol 174:R139\u2013R144","journal-title":"Eur J Endocrinol"},{"key":"909_CR10","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00401-014-1270-6","volume":"127","author":"SJ Larkin","year":"2014","unstructured":"Larkin SJ, Preda V, Karavitaki N et al (2014) BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma. Acta Neuropathol 127:927\u2013929. \n                    https:\/\/doi.org\/10.1007\/s00401-014-1270-6","journal-title":"Acta Neuropathol"},{"key":"909_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/nan.12201","volume":"41","author":"L Schweizer","year":"2015","unstructured":"Schweizer L, Capper D, H\u00f6lsken A et al (2015) BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke\u2019s cleft cysts. Neuropathol Appl Neurobiol 41:733\u2013742. \n                    https:\/\/doi.org\/10.1111\/nan.12201","journal-title":"Neuropathol Appl Neurobiol"},{"key":"909_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv310","author":"PK Brastianos","year":"2016","unstructured":"Brastianos PK, Shankar GM, Gill CM et al (2016) Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. J Natl Cancer Inst. \n                    https:\/\/doi.org\/10.1093\/jnci\/djv310","journal-title":"J Natl Cancer Inst"},{"key":"909_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11102-015-0663-4","volume":"19","author":"SJB Aylwin","year":"2016","unstructured":"Aylwin SJB, Bodi I, Beaney R (2016) Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor. Pituitary 19:544\u2013546. \n                    https:\/\/doi.org\/10.1007\/s11102-015-0663-4","journal-title":"Pituitary"},{"key":"909_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2217\/cns-2016-0034","volume":"6","author":"A Roque","year":"2017","unstructured":"Roque A, Odia Y (2017) BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors. CNS Oncol 6:95\u201399. \n                    https:\/\/doi.org\/10.2217\/cns-2016-0034","journal-title":"CNS Oncol"},{"key":"909_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-017-3311-0","author":"E Rostami","year":"2017","unstructured":"Rostami E, Witt Nystr\u00f6m P, Libard S et al (2017) Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy. Acta Neurochir. \n                    https:\/\/doi.org\/10.1007\/s00701-017-3311-0","journal-title":"Acta Neurochir"},{"key":"909_CR16","doi-asserted-by":"publisher","DOI":"10.3171\/2017.11.JNS172373","author":"BT Himes","year":"2018","unstructured":"Himes BT, Ruff MW, Van Gompel JJ et al (2018) Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report. J Neurosurg. \n                    https:\/\/doi.org\/10.3171\/2017.11.JNS172373","journal-title":"J Neurosurg"},{"key":"909_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien\u2013Dindo classification of surgical complications. Ann Surg 250:187\u2013196. \n                    https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2","journal-title":"Ann Surg"},{"key":"909_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3171\/jns.2007.106.3.400","volume":"106","author":"I Laufer","year":"2007","unstructured":"Laufer I, Anand VK, Schwartz TH (2007) Endoscopic, endonasal extended transsphenoidal, transplanum transtuberculum approach for resection of suprasellar lesions. J Neurosurg 106:400\u2013406. \n                    https:\/\/doi.org\/10.3171\/jns.2007.106.3.400","journal-title":"J Neurosurg"},{"key":"909_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/jns.1990.73.1.0003","volume":"73","author":"MG Ya\u015fargil","year":"1990","unstructured":"Ya\u015fargil MG, Curcic M, Kis M et al (1990) Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 73:3\u201311. \n                    https:\/\/doi.org\/10.3171\/jns.1990.73.1.0003","journal-title":"J Neurosurg"},{"key":"909_CR20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3171\/JNS\/2008\/108\/4\/0715","volume":"108","author":"AB Kassam","year":"2008","unstructured":"Kassam AB, Gardner PA, Snyderman CH et al (2008) Evolution of the endonasal approach for craniopharyngiomas expanded endonasal approach, a fully endoscopic transnasal approach for the resection of midline suprasellar craniopharyngiomas: a new classification based on the infundibulum. J Neurosurg 108:715\u2013728. \n                    https:\/\/doi.org\/10.3171\/JNS\/2008\/108\/4\/0715","journal-title":"J Neurosurg"},{"key":"909_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2176\/nmc.37.141","volume":"37","author":"M Samii","year":"1997","unstructured":"Samii M, Tatagiba M (1997) Surgical management of craniopharyngiomas: a review. Neurol Med Chir (Tokyo) 37:141\u2013149. \n                    https:\/\/doi.org\/10.2176\/nmc.37.141","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"909_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00701-004-0295-3","volume":"146","author":"JM Pascual","year":"2004","unstructured":"Pascual JM, Gonz\u00e1lez-Llanos F, Barrios L, Roda JM (2004) Intraventricular craniopharyngiomas: topographical classification and surgical approach selection based on an extensive overview. Acta Neurochir 146:785\u2013802. \n                    https:\/\/doi.org\/10.1007\/s00701-004-0295-3","journal-title":"Acta Neurochir"},{"key":"909_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s11102-015-0669-y","volume":"18","author":"G Marucci","year":"2015","unstructured":"Marucci G, de Biase D, Zoli M et al (2015) Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells. Pituitary 18:905\u2013911. \n                    https:\/\/doi.org\/10.1007\/s11102-015-0669-y","journal-title":"Pituitary"},{"key":"909_CR24","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1242\/dev.150490","volume":"144","author":"S Haston","year":"2017","unstructured":"Haston S, Pozzi S, Carreno G et al (2017) MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma. Development 144:2141\u20132152","journal-title":"Development"},{"key":"909_CR25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"PTC Wan","year":"2004","unstructured":"Wan PTC, Garnett MJ, Roe SM et al (2004) Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116:855\u2013867. \n                    https:\/\/doi.org\/10.1016\/S0092-8674(04)00215-6","journal-title":"Cell"},{"key":"909_CR26","doi-asserted-by":"publisher","DOI":"10.3171\/2017.1.JNS162232","author":"SB Omay","year":"2017","unstructured":"Omay SB, Chen Y-N, Almeida JP et al (2017) Do craniopharyngioma molecular signatures correlate with clinical characteristics? J Neurosurg. \n                    https:\/\/doi.org\/10.3171\/2017.1.JNS162232","journal-title":"J Neurosurg"},{"key":"909_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11060-015-1757-6","volume":"123","author":"JH Kim","year":"2015","unstructured":"Kim JH, Paulus W, Heim S (2015) BRAF V600E mutation is a useful marker for differentiating Rathke\u2019s cleft cyst with squamous metaplasia from papillary craniopharyngioma. J Neurooncol 123:189\u2013191. \n                    https:\/\/doi.org\/10.1007\/s11060-015-1757-6","journal-title":"J Neurooncol"},{"key":"909_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00401-011-0841-z","volume":"122","author":"D Capper","year":"2011","unstructured":"Capper D, Preusser M, Habel A et al (2011) Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol 122:11\u201319. \n                    https:\/\/doi.org\/10.1007\/s00401-011-0841-z","journal-title":"Acta Neuropathol"},{"key":"909_CR29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/modpathol.2014.150","volume":"28","author":"RT Jones","year":"2015","unstructured":"Jones RT, Abedalthagafi MS, Brahmandam M et al (2015) Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia. Mod Pathol 28:596\u2013606. \n                    https:\/\/doi.org\/10.1038\/modpathol.2014.150","journal-title":"Mod Pathol"},{"key":"909_CR30","first-page":"77","volume":"18","author":"S Sartoretti-Schefer","year":"1997","unstructured":"Sartoretti-Schefer S, Wichmann W, Aguzzi A, Valavanis A (1997) MR differentiation of adamantinous and squamous-papillary craniopharyngiomas. Am J Neuroradiol. 18:77\u201387","journal-title":"Am J Neuroradiol"},{"key":"909_CR31","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2016.59.5.466","author":"IH Lee","year":"2016","unstructured":"Lee IH, Zan E, Bell WR et al (2016) Craniopharyngiomas: radiological differentiation of two types. J Korean Neurosurg Soc. \n                    https:\/\/doi.org\/10.3340\/jkns.2016.59.5.466","journal-title":"J Korean Neurosurg Soc"},{"key":"909_CR32","doi-asserted-by":"publisher","DOI":"10.3171\/2017.4.JNS163113","author":"Q Yue","year":"2017","unstructured":"Yue Q, Yu Y, Shi Z et al (2017) Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features. J Neurosurg. \n                    https:\/\/doi.org\/10.3171\/2017.4.JNS163113","journal-title":"J Neurosurg"},{"key":"909_CR33","doi-asserted-by":"publisher","DOI":"10.3171\/2016.9.FOCUS16304","author":"R Prieto","year":"2016","unstructured":"Prieto R, Pascual JM, Rosdolsky M et al (2016) Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors. Neurosurg Focus. \n                    https:\/\/doi.org\/10.3171\/2016.9.FOCUS16304","journal-title":"Neurosurg Focus"},{"key":"909_CR34","first-page":"25","volume":"25","author":"K Sato","year":"2006","unstructured":"Sato K, Oka H, Utsuki S et al (2006) Ciliated craniopharyngioma may arise from Rathke cleft cyst. Clin Neuropathol 25:25\u201328","journal-title":"Clin Neuropathol"},{"key":"909_CR35","doi-asserted-by":"publisher","DOI":"10.3171\/2016.9.FOCUS16317","author":"M Zoli","year":"2016","unstructured":"Zoli M, Sambati L, Milanese L et al (2016) Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas. Neurosurg Focus. \n                    https:\/\/doi.org\/10.3171\/2016.9.FOCUS16317","journal-title":"Neurosurg Focus"},{"key":"909_CR36","doi-asserted-by":"publisher","DOI":"10.3171\/2014.3.JNS131521","author":"LM Cavallo","year":"2014","unstructured":"Cavallo LM, Frank G, Cappabianca P et al (2014) The endoscopic endonasal approach for the management of craniopharyngiomas: a series of 103 patients. J Neurosurg. \n                    https:\/\/doi.org\/10.3171\/2014.3.JNS131521","journal-title":"J Neurosurg"},{"key":"909_CR37","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3171\/2016.9.FOCUS16299","volume":"41","author":"N Moussazadeh","year":"2016","unstructured":"Moussazadeh N, Prabhu V, Bander ED et al (2016) Endoscopic endonasal versus open transcranial resection of craniopharyngiomas: a case-matched single-institution analysis. Neurosurg Focus 41:E7. \n                    https:\/\/doi.org\/10.3171\/2016.9.FOCUS16299","journal-title":"Neurosurg Focus"},{"key":"909_CR38","doi-asserted-by":"publisher","DOI":"10.23736\/S0390-5616.17.04171-6","author":"M Ottenhausen","year":"2017","unstructured":"Ottenhausen M, Rumalla K, La Corte E et al (2017) Treatment strategies for craniopharyngiomas. J Neurosurg Sci. \n                    https:\/\/doi.org\/10.23736\/S0390-5616.17.04171-6","journal-title":"J Neurosurg Sci"},{"key":"909_CR39","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3171\/2010.11.JNS10670","volume":"114","author":"P Mortini","year":"2011","unstructured":"Mortini P, Losa M, Pozzobon G et al (2011) Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg 114:1350\u20131359. \n                    https:\/\/doi.org\/10.3171\/2010.11.JNS10670","journal-title":"J Neurosurg"},{"key":"909_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-018-3567-z","author":"I Younus","year":"2018","unstructured":"Younus I, Forbes JA, Ord\u00f3\u00f1ez-Rubiano EG et al (2018) Radiation therapy rather than prior surgery reduces extent of resection during endonasal endoscopic reoperation for craniopharyngioma. Acta Neurochir (Wien). \n                    https:\/\/doi.org\/10.1007\/s00701-018-3567-z","journal-title":"Acta Neurochir (Wien)"},{"key":"909_CR41","doi-asserted-by":"publisher","DOI":"10.3171\/2016.1.JNS152238","author":"S Dhandapani","year":"2016","unstructured":"Dhandapani S, Singh H, Negm HM et al (2016) Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas. J Neurosurg. \n                    https:\/\/doi.org\/10.3171\/2016.1.JNS152238","journal-title":"J Neurosurg"},{"key":"909_CR42","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1002011.Inhibition","volume":"363","author":"K Flaherty","year":"2010","unstructured":"Flaherty K, Puzanov I, Kim K et al (2010) Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363:809\u2013819. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1002011.Inhibition","journal-title":"N Engl J Med"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-018-0909-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-018-0909-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-018-0909-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T19:21:50Z","timestamp":1567624910000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-018-0909-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["909"],"URL":"https:\/\/doi.org\/10.1007\/s11102-018-0909-z","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,5]]},"assertion":[{"value":"5 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}